Lung Cancer

Top Story

VIDEO: Additional treatment with ALK inhibitor after progression shows promise in non-small cell lung cancer

September 18, 2017

CHICAGO — Ensartinib shows promise for the treatment of patients with anaplastic lymphoma kinase-positive non-small cell lung cancer, Makenzi Evangelist, MD, said at International Association for the Study of Lung Cancer Multidisciplinary Symposium in Thoracic Oncology.

In the Journals

Patients with HIV who smoke at greater risk for lung cancer mortality

September 18, 2017
Patients with HIV who adhere to antiretroviral therapy but smoke are significantly more likely to die from lung cancer than from AIDS-related causes; therefore, smoking…
Meeting News

Smoking status does not impact outcomes with anti-PD-1 therapy

September 18, 2017
CHICAGO — Smoking status did not affect biomarkers, immune-related adverse events or survival among patients treated with anti-PD-1 therapy for non-small cell lung…
Meeting NewsVideo

VIDEO: Stereotactic ablative radiotherapy, nivolumab trial warrants further investigation

September 17, 2017
CHICAGO — Further investigation is warranted regarding treatment with stereotactic ablative radiotherapy in combination with anti-PD-1 therapy for patients with…
More Headlines »
CME Article

Pulmonary Complications of Pediatric Neurological Diseases

Pediatric Annals, April 2010, Volume 39 Issue 4
Significant pulmonary compromise is associated with a spectrum of neurological diseases in the pediatric population…
More »
Video
Meeting News

VIDEO: Stereotactic ablative radiotherapy, nivolumab trial warrants further investigation

September 17, 2017
More »
Advertisement
Advertisement